Patents by Inventor Steven Edwards

Steven Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030232828
    Abstract: The present invention provides compounds of formula I and the use thereof for the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: June 3, 2003
    Publication date: December 18, 2003
    Applicant: Wyeth
    Inventors: Ronald Charles Bernotas, Steven Edward Lenicek, Schuyler A. Antane, Ping Zhou, Yanfang Li
  • Publication number: 20030212069
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: March 5, 2003
    Publication date: November 13, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pineiro-Nunez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 6638972
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: October 28, 2003
    Assignee: Wyeth
    Inventors: Michael Gerard Kelly, Lynne Padilla Greenblatt, Gan Zhang, Yvette L. Palmer, Steven Edward Lenicek
  • Publication number: 20030199505
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: February 26, 2003
    Publication date: October 23, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pineiro-Nunez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030199504
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: February 28, 2003
    Publication date: October 23, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pineiro-Nunez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 6635657
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: October 21, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Carl Penman Denny, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Piñeiro-Núñez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030195223
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: April 25, 2002
    Publication date: October 16, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Valentine Joseph Klimkowski, John Joseph Masters, David Mendel, Guy Milot, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030191153
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: February 25, 2003
    Publication date: October 9, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pineiro-Nunez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030182173
    Abstract: A system and method for improved capacity planning and deployment is presented. Codified skills are used to generate job roles and employee skill profiles. Job roles include codified skills corresponding to the type of skills an employee needs to effectively perform a job assignment corresponding to his job role. An employee skill profile includes codified skills corresponding to the employees' capabilities. Job roles and employee skill profiles may be compared in various ways that allows an organization to effectively hire, develop, and manage employees.
    Type: Application
    Filed: March 21, 2002
    Publication date: September 25, 2003
    Applicant: International Business Machines Corporation
    Inventors: Daniel D'Elena, Steven Edward Heise, Anthony Edward Martinez, Ronald James Salpietra
  • Publication number: 20030182178
    Abstract: A system and method for skill proficiencies acquisitions is presented. Job roles are compared with employee skill profiles to determine which skills a corresponding employee needs developed. A skill map is generated which includes skill development activity options. Skill development activity options may include attending a seminar, reading a book, or participating in a mentoring program. An employee selects a skill development activity that is suitable to his work routine and learning style. A skill proficiency rating is determined after the conclusion of the skill development activity. The new skill and proficiency rating are recorded in the employee's skill profile.
    Type: Application
    Filed: March 21, 2002
    Publication date: September 25, 2003
    Applicant: International Business Machines Corporation
    Inventors: Daniel D'Elena, Steven Edward Heise, Anthony Edward Martinez, Ronald James Salpietra
  • Publication number: 20030182103
    Abstract: A method for converting to Unicode, in a Java Input Method Editor (“IME”), the encoding formats of a character code unit, including selecting an encoding format, receiving, through a computer user interface, in an IME, at least one character code unit having the encoding format and an encoding base, and displaying the character code unit through the computer user interface. Embodiments also include converting the encoding format of the character code unit to Unicode, thereby creating a Unicode code point, displaying, through the computer user interface, a glyph corresponding to the Unicode code point, and transferring the Unicode code point to an application.
    Type: Application
    Filed: March 21, 2002
    Publication date: September 25, 2003
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventor: Steven Edward Atkin
  • Patent number: 6610704
    Abstract: This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: August 26, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Steven Edward Hall, David Kent Herron, Sajan Joseph, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Marta Maria Pineiro-Nunez, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030153599
    Abstract: The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
    Type: Application
    Filed: October 3, 2002
    Publication date: August 14, 2003
    Applicant: Wyeth
    Inventors: Michael Gerard Kelly, Lynne Padilla Greenblatt, Gan Zhang, Yvette L. Palmer, Steven Edward Lenicek
  • Patent number: 6605626
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: August 12, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson Jr., Steven Edward Hall, David Kent Herron, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 6596882
    Abstract: Disclosed is a method of recovering and purifying 3,4-epoxy-1-butene (epoxybutene) from an epoxidation effluent gas obtained by the vapor phase, catalytic, partial oxidation of 1,3-butadiene (butadiene) with molecular oxygen in the presence of a silver catalyst wherein the epoxybutene-laden epoxidation product gas is reacted with a water-miscible solvent to absorb the epoxybutene. The disclosed process includes a method of separating epoxybutene from the solvent and other reaction by-products by a novel combination of distillation and decantation steps.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: July 22, 2003
    Assignee: Eastman Chemical Company
    Inventors: Scott Donald Barnicki, Jerome Leonard Stavinoha, Jr., Robert Sterling Kline, Steven Edward Briley, Jackie Lee Hamilton
  • Publication number: 20030131042
    Abstract: A method, system and apparatus for allowing a device to be shared among partitions of a logically partitioned computer system are provided. A table is used to cross-reference a list of devices with a list of partitions that may share the devices. When a partition needs to use a device, it sends a request to a control node. Upon receiving the request, the control node consults the table to determine whether the partition has permission to use the device. If so and the device is currently idle, the control node will reassign the device to the requesting partition. If the device is busy, the control node will so notify the partition. After the requesting partition has used the device, the device will be reassigned to the partition to which it was originally assigned.
    Type: Application
    Filed: January 10, 2002
    Publication date: July 10, 2003
    Applicant: International Business Machines Corporation
    Inventors: Faisal M. Awada, Joe Nathan Brown, Mark Steven Edwards, Arthur James Tysor
  • Patent number: 6586459
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 1, 2003
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffry Bernard Franciskovich, Theodore Goodson, Junior, Steven Edward Hall, David Kent Herron, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Patent number: 6583173
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: June 24, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Trelia Joyce Craft, Jeffrey Bernard Franciskovich, Theodore Goodson, Junior, Steven Edward Hall, David Kent Herron, Valentine Joseph Klimkowski, Jeffrey Alan Kyle, John Joseph Masters, David Mendel, Guy Milot, Jason Scott Sawyer, Robert Theodore Shuman, Gerald Floyd Smith, Anne Louise Tebbe, Jennifer Marie Tinsley, Leonard Crayton Weir, James Howard Wikel, Michael Robert Wiley, Ying Kwong Yee
  • Publication number: 20030114320
    Abstract: A synthetic lubricant base stock is provided hang a kinematic viscosity at 100° C. of from 5 to about 300 cS and a VI greater than 100. The base stock comprises random co-oligomers of an alpha olefin or mixtures thereof and an olefinic substituted aromatic compound which co-oligomers are prepared in the presence of a Friedel-Crafts catalyst.
    Type: Application
    Filed: September 10, 2002
    Publication date: June 19, 2003
    Inventors: Margaret May-Som Wu, Steven Edward Donnachie, James Thomas Carey, Walter David Vann, Norman Yang, Dilip Surana
  • Publication number: 20030110021
    Abstract: A two-phase system and method for determining a display order of characters in a multilingual domain name. First, inferencing resolves the direction of indeterminate characters, such as the fall stop or “dot”, hyphen-minus, Arabic numeral, and European numeral, during which each character is assigned a strong direction left or right. Second, reordering takes the fully resolved characters and generates a display ordering for them. The inferencing phase is accomplished in several passes including assigning Arabic and Hebrew letters right-to-left direction, and assigning left-to-right direction to full stops and other alphabetic characters. Next, directions of digits are resolved by assigning all Arabic numerals a right-to-left direction; and assigning all European numerals left-to-right direction, unless the European numeral is surrounded by right-to-left characters.
    Type: Application
    Filed: June 26, 2001
    Publication date: June 12, 2003
    Applicant: International Business Machines Corporation
    Inventor: Steven Edward Atkin